Royce & Associates LP boosted its holdings in CarMax, Inc. (NYSE:KMX – Get Rating) by 216.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 24,975 shares of the company’s stock after purchasing an additional 17,075 shares during the period. Royce & Associates LP’s holdings in CarMax were worth $1,649,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in KMX. Curi Wealth Management LLC lifted its stake in shares of CarMax by 595.2% in the 2nd quarter. Curi Wealth Management LLC now owns 292 shares of the company’s stock valued at $26,000 after acquiring an additional 250 shares during the last quarter. MV Capital Management Inc. grew its position in CarMax by 233.7% during the 2nd quarter. MV Capital Management Inc. now owns 297 shares of the company’s stock worth $27,000 after acquiring an additional 208 shares during the last quarter. Clear Street Markets LLC increased its stake in CarMax by 410.6% in the 2nd quarter. Clear Street Markets LLC now owns 337 shares of the company’s stock worth $30,000 after purchasing an additional 271 shares during the period. Ronald Blue Trust Inc. bought a new stake in CarMax in the second quarter valued at approximately $30,000. Finally, Whittier Trust Co. boosted its stake in shares of CarMax by 72.5% during the third quarter. Whittier Trust Co. now owns 509 shares of the company’s stock valued at $34,000 after purchasing an additional 214 shares during the period.
Wall Street Analyst Weigh In
Several research analysts recently commented on the stock. StockNews.com raised shares of CarMax to a “sell” rating in a research note on Friday, December 9th. Stephens decreased their price objective on shares of CarMax from $64.00 to $53.00 in a research report on Friday, December 23rd. Bank of America cut their target price on CarMax from $100.00 to $49.00 and set an “underperform” rating on the stock in a research note on Friday, December 23rd. Wedbush cut their price objective on CarMax from $67.00 to $55.00 in a research report on Tuesday, December 20th. Finally, JPMorgan Chase & Co. downgraded CarMax from a “neutral” rating to an “underweight” rating and set a $60.00 target price for the company. in a report on Wednesday, January 11th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $69.40.
Insiders Place Their Bets
CarMax Stock Down 0.9 %
Shares of CarMax stock opened at $66.72 on Wednesday. CarMax, Inc. has a 1 year low of $52.10 and a 1 year high of $114.43. The firm has a market cap of $10.54 billion, a price-to-earnings ratio of 18.69, a PEG ratio of 2.90 and a beta of 1.44. The company has a 50-day moving average of $64.71 and a 200 day moving average of $75.67. The company has a debt-to-equity ratio of 3.21, a current ratio of 2.57 and a quick ratio of 0.81.
CarMax (NYSE:KMX – Get Rating) last announced its earnings results on Thursday, December 22nd. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.34). CarMax had a net margin of 1.82% and a return on equity of 10.69%. The business had revenue of $6.51 billion for the quarter, compared to the consensus estimate of $7.18 billion. During the same period in the prior year, the business posted $1.63 EPS. CarMax’s revenue for the quarter was down 23.7% on a year-over-year basis. As a group, sell-side analysts anticipate that CarMax, Inc. will post 2.83 earnings per share for the current fiscal year.
CarMax, Inc is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations.
- Get a free copy of the StockNews.com research report on CarMax (KMX)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for CarMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CarMax and related companies with MarketBeat.com's FREE daily email newsletter.